US Patent 7993829 HPRP4s modifiers of the p53 pathway and methods of use

Patent 7993829 was granted and assigned to Exelixis on August, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Exelixis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7993829

Date of Patent

August 9, 2011

Patent Application Number

11627831

Date Filed

January 26, 2007

Patent Primary Examiner

‌

Laura B Goddard

Patent abstract

Human hPRP4 genes are identified as modulators of the p53 pathway, and thus are therapeutic targets for disorders associated with defective p53 function. Methods for identifying modulators of p53, comprising screening for agents that modulate the activity of hPRP4 are provided.